Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) Net Margin (2020 - 2025)

SOPHiA GENETICS's Net Margin history spans 6 years, with the latest figure at 91.99% for Q4 2025.

  • On a quarterly basis, Net Margin fell 1346.0% to 91.99% in Q4 2025 year-over-year; TTM through Dec 2025 was 98.32%, a 619.0% decrease, with the full-year FY2025 number at 98.32%, down 619.0% from a year prior.
  • Net Margin hit 91.99% in Q4 2025 for SOPHiA GENETICS, up from 96.27% in the prior quarter.
  • Over the last five years, Net Margin for SOPH hit a ceiling of 78.53% in Q4 2024 and a floor of 230.37% in Q1 2022.
  • Historically, Net Margin has averaged 136.88% across 5 years, with a median of 125.95% in 2021.
  • Biggest five-year swings in Net Margin: surged 38572bps in 2021 and later tumbled -9314bps in 2022.
  • Tracing SOPH's Net Margin over 5 years: stood at 205.03% in 2021, then soared by 47bps to 108.23% in 2022, then crashed by -30bps to 141.13% in 2023, then skyrocketed by 44bps to 78.53% in 2024, then dropped by -17bps to 91.99% in 2025.
  • Business Quant data shows Net Margin for SOPH at 91.99% in Q4 2025, 96.27% in Q3 2025, and 114.01% in Q2 2025.